CVS outlook revised to positive by Moody’s on turnaround
1 source
·7h ago
company
In the news · 5
Highlights CVS Group (LSE:CVSG) has provided fresh evidence on veterinary demand and business execution through its latest trading update. Smallcap sentiment remains selective as investors distinguish recurring service revenue from balance-sheet and labour risks. Current London s…
CVS Health raised guidance after a strong Q2, but shares fell nearly 5% after executives flagged expected Caremark membership declines in 2026 and a 340B headwind persisting into 2027.
Amazon’s pharmacy now offers steep discounts for weight-loss drugs, down from as much as $1,500.
More in Consumer